Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Medicare Rx May Have Little Effect On VA Health System, Agency Says

This article was originally published in The Pink Sheet Daily

Executive Summary

Department of Veterans Affairs expects an actuary report on the effect of the Medicare Rx program in about eight weeks, official tells a House Veterans’ Affairs/Health Subcommittee hearing March 30. The hearing reopens debate on a drug-only health benefit for veterans.

You may also be interested in...

Veterans Rx-Only Plan Would Reduce Price Negotiating Power, VA Says

VA opposes the bill because it could lead to an increase in the amount and price of pharmaceuticals purchased. The department would prefer to be responsible for all the health care needs of veterans, Deputy Secretary Mansfield says during Senate hearing.

Merck Tax Settlement Could Be Smaller Than GSK’s $3.4 Bil. IRS Deal

A possible settlement between Merck and tax authorities could be significantly smaller than GlaxoSmithKline's recent settlement with the IRS based on the companies' projected liability





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts